Contact Hour Designation
This online independent study activity is credited for 4 contact hours.
Course Purpose
The purpose of this course is to provide healthcare professionals with a brief overview Preeclampsia and Hemolysis, Elevated Liver enzymes, and Low Platelet (HELLP) syndrome, their clinical presentations, risk factors, and treatment options.
Overview
Preeclampsia and Hemolysis, Elevated Liver enzymes, and Low Platelet (HELLP) syndrome are two serious pregnancy conditions that pose a substantial risk to the health of pregnant women and the fetus. Preeclampsia is a hypertensive disorder that usually develops after 20 weeks of gestation and is characterized by extremely high blood pressure and protein presence in the urine, and Hemolysis, Elevated Liver enzymes, and Low Platelet (HELLP) syndrome is a life-threatening variant of preeclampsia usually seen in the later stages of pregnancy or soon after childbirth. This course defines the cause, clinical presentation, and risk factors associated with Preeclampsia and HELLP syndrome. Additionally, it discusses treatment options and vital nursing considerations for both conditions that can be implemented to manage symptoms and improve health outcomes.
Objectives
Upon completion of the independent study, the learner will be able to:
- Describe preeclampsia and its four subtypes.
- Describe HELLP syndrome and its classifications.
- Identify risk factors for preeclampsia and HELLP syndrome.
- Review the signs and symptoms of preeclampsia and HELLP syndrome.
- Differentiate between preeclampsia and HELLP syndrome and their treatment options.
Policy Statement
This activity has been planned and implemented in accordance with the policies of FastCEForLess.com.
Disclosures
Fast CE For Less, Inc. and its authors have no disclosures. There is no commercial support.
